JPS6318706B2 - - Google Patents
Info
- Publication number
- JPS6318706B2 JPS6318706B2 JP55169207A JP16920780A JPS6318706B2 JP S6318706 B2 JPS6318706 B2 JP S6318706B2 JP 55169207 A JP55169207 A JP 55169207A JP 16920780 A JP16920780 A JP 16920780A JP S6318706 B2 JPS6318706 B2 JP S6318706B2
- Authority
- JP
- Japan
- Prior art keywords
- hemoglobin
- methemoglobin
- allosteric
- dinitrophenyl
- glycosylated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000001554 Hemoglobins Human genes 0.000 claims description 62
- 108010054147 Hemoglobins Proteins 0.000 claims description 62
- 108010061951 Methemoglobin Proteins 0.000 claims description 38
- 125000001917 2,4-dinitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1*)[N+]([O-])=O)[N+]([O-])=O 0.000 claims description 26
- 102000017011 Glycated Hemoglobin A Human genes 0.000 claims description 26
- 108010014663 Glycated Hemoglobin A Proteins 0.000 claims description 26
- 230000003281 allosteric effect Effects 0.000 claims description 25
- 210000003743 erythrocyte Anatomy 0.000 claims description 14
- 239000012086 standard solution Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- 230000008856 allosteric binding Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 5
- 238000005259 measurement Methods 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000012266 salt solution Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 2
- 150000002314 glycerols Chemical class 0.000 claims description 2
- 239000003446 ligand Substances 0.000 description 14
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 11
- 230000027455 binding Effects 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- -1 alkyl isocyanides Chemical class 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 150000003278 haem Chemical class 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 6
- 229940068041 phytic acid Drugs 0.000 description 6
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- WDCYWAQPCXBPJA-UHFFFAOYSA-N 1,3-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC([N+]([O-])=O)=C1 WDCYWAQPCXBPJA-UHFFFAOYSA-N 0.000 description 2
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 108010062374 Myoglobin Proteins 0.000 description 2
- 102000036675 Myoglobin Human genes 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 108010002255 deoxyhemoglobin Proteins 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- XOHUEYCVLUUEJJ-UHFFFAOYSA-I 2,3-Diphosphoglycerate Chemical compound [O-]P(=O)([O-])OC(C(=O)[O-])COP([O-])([O-])=O XOHUEYCVLUUEJJ-UHFFFAOYSA-I 0.000 description 1
- OBJOZRVSMLPASY-UHFFFAOYSA-N 8-hydroxypyrene-1,3,6-trisulfonic acid Chemical compound C1=C2C(O)=CC(S(O)(=O)=O)=C(C=C3)C2=C2C3=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C2=C1 OBJOZRVSMLPASY-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- CTPQAXVNYGZUAJ-UHFFFAOYSA-N Inositol pentaphosphate Natural products OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O CTPQAXVNYGZUAJ-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 108010064719 Oxyhemoglobins Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- CTPQAXVNYGZUAJ-UYSNGIAKSA-N [(1s,2r,4s,5r)-3-hydroxy-2,4,5,6-tetraphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound OC1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)C(OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O CTPQAXVNYGZUAJ-UYSNGIAKSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- RRUDCFGSUDOHDG-UHFFFAOYSA-N acetohydroxamic acid Chemical compound CC(O)=NO RRUDCFGSUDOHDG-UHFFFAOYSA-N 0.000 description 1
- 229960001171 acetohydroxamic acid Drugs 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 239000012637 allosteric effector Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002527 isonitriles Chemical class 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- FSBLVBBRXSCOKU-UHFFFAOYSA-N n-butyl isocyanide Chemical compound CCCC[N+]#[C-] FSBLVBBRXSCOKU-UHFFFAOYSA-N 0.000 description 1
- UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- RCIBIGQXGCBBCT-UHFFFAOYSA-N phenyl isocyanide Chemical class [C-]#[N+]C1=CC=CC=C1 RCIBIGQXGCBBCT-UHFFFAOYSA-N 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/723—Glycosylated haemoglobin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/795—Porphyrin- or corrin-ring-containing peptides
- G01N2333/805—Haemoglobins; Myoglobins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/104998—Glucose, ketone, nitrate standard or control
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
æ¬çºæã¯ã°ãªã³ã·ã«åãããïŒglycosylatedïŒ
ãã¢ã°ããã³æž¬å®çšæšæºæ¶²ã«é¢ããã æ¬çºæã¯è¡æ¶²äžã®ã°ãªã³ã·ã«åãã¢ã°ããã³æž¬
å®ã«äŸ¿å©ãªæšæºè©Šè¬ã«é¢ããããã¢ã°ããã³åã¯
ã¡ããã¢ã°ããã³ãšïŒïŒïŒâãžãããèªå°äœãã
ã¢ã°ããã³ã®ã¢ãã¹ããªãã¯ïŒallostericïŒãªçµ
åäœçœ®ããããã¯ããæ§ãªãã¢ã°ããã³åã¯ã¡ã
ãã¢ã°ããã³ã®ïŒïŒïŒâãžãããããšãã«èªå°äœ
ïŒä¹è³25ïŒ ãšã®æ··åç©ã¯é©åœãªæšæºæ¶²ã§ãããæ
ã«æ¬çºæã®æšæºæ¶²ã¯ãã¢ã°ããã³ã®ïŒ²ããã³ïŒŽå€
æ ã«äŒŽãªãã¹ãã¯ãã«ç¹æ§ã«é¢ããŠã°ãªã³ã·ã«å
ããã³éã°ãªã³ã·ã«åãã¢ã°ããã³ã®æ¬æ··åç©ã
å³ã¡åæã°ãªã³ã·ã«åãã¢ã°ããã³æšæºæ¶²ã§ã
ãããã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³ã®ã®ã¢ã
ã¹ããªãã¯ãªçµåäœçœ®ãïŒïŒïŒâãžãããããšã
ã«èªå°äœã«ãã€ãŠä¿è·ãããŠãããã¢ã°ããã³å
ã¯ã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžãããããšãã«
èªå°äœãïŒïŒ ã11ïŒ ããã³20ïŒ å«ãã§ãã代衚ç
æšæºæ¶²ã¯è©Šéšçšå ·ç®±ã«å ããããã ãã¢ã°ããã³ã¯ïŒã¢ãã¹ããªãã¯ãªåœ¢ã
ïŒtaughtïŒåãšïŒ²ïŒrelaxedïŒåã§ååšããããã
ãã®åã¯ç°ãªãç©ççååŠçæ§è³ªããã¡ïŒ²ãšïŒŽã
ã¢ã°ããã³ã®çžå¯Ÿéã¯çŽ«å€ç·ãèµ€å€ç·ãå¯èŠç·ã
æ žç£æ°å ±é³Žããã³é»ååè»¢å ±é³Žåå åŠã®æ§ãªãã®
åéã§èªããããæ¹æ³ã«ãã€ãŠæž¬å®ã§ãããäŸã
ã°ãã«ããã®Biochemistry17ïŒNo.17ïŒ3641
ïŒ1978ïŒã¯ãã¢ã°ããã³èªå°äœã®åžåã¹ãã¯ãã«ã
å³ã¡ïŒ²â転äœãé äœåãšã€ãã·ããŒã«ãã¯ãµã
ã¹ããšã€ãçµåã®åœæ°ãšããŠèšè¿°ããŠããããã¢
ã°ããã³ã®ïŒ²ãšïŒŽç¶æ ããèå¥ããä»ã®æ¹æ³ã«ã¯
埪ç°ïŒè²æ§ããã³ååŠåå¿æ§ãããããšïŒŽç¶æ
ã®çžå¯Ÿéã¯çµç¹æ³ããã³éåæ³ã®äž¡æ³ã«ãã€ãŠæž¬
å®ã§ããã é«æ¿åºŠã®ã°ãªã³ã·ã«åãã¢ã°ããã³ã¯ç³å°¿ç ã
䌎ãªããšç¥ãããŠãããã°ãªã³ã·ã«åãã¢ã°ãã
ã³ã¯éç³å°¿ç æ£è ã§ã¯å šãã¢ã°ããã³çŽïŒïŒ ã®æ¿
床ã§ããããç³å°¿ç æ£è ã¯ãã®ïŒâïŒåããã€ã
ïŒScienceïŒ200ïŒ1978幎ïŒæïŒæ¥ïŒãã°ãªã³ã·ã«å
ãã¢ã°ããã³æ¿åºŠã¯é·æéã«ãããæ£è ã®å¹³åè¡
ç³æ¿åºŠã®ææ°ãšãªãããã®ææ°ã¯è¡ç³ã®çæå€å
ïŒæéçïŒã«åœ±é¿ãããããããã€ãŠç³å°¿ç æ£è
ã®è¡ç³ç¶æ 調æŽã®æ¯èŒç粟å¯ãªåæ ãšãªãã ã°ãªã³ã·ã«åããããã¢ã°ããã³ã¯éåžžHbA
ãšãããåã¯ãããã¯ãããã°ã©ã管äžè¿ éã«ç§»
åããã®ã§è¿ éãã¢ã°ããã³ãšãããäžè¬ã«ã¯ã
ããã°ã©ãæ³åã¯é»æ°æ³³åæ³ã«ãã€ãŠæž¬å®ãã
ãã æè¿ïŒæ¬åºé¡è ãšå ±éã§ããç±³åœç¹èš±éãçªå·
973368ïŒéã°ãªã³ã·ã«åãã¢ã°ããã³ãã¢ãã¹ã
ãªãã¯ãªäœçœ®çµåæ§ç©è³ªãšåå¿ãããå Žåã®ãã¢
ã°ããã³ã®ïŒ²ãšïŒŽã¢ãã¹ããªãã¯å矀ã®å¹³è¡¡ç§»å
ãç£èŠããããšã«ãã€ãŠè¡æ¶²äžã®ã°ãªã³ã·ã«åã
ã¢ã°ããã³éã枬å®ã§ããããšãçºèŠãããã®ã§
ããããã®åå¿ã¯ãã¢ã°ããã³ã®éã°ãªã³ã·ã«å
éšåã®ïŒ²ããã¢ãã¹ããªãã¯åãžã®ç§»åãèµ·
ããè¡æ¶²è©Šæäžã®ã°ãªã³ã·ã«åãã¢ã°ããã³ã¯ã°
ãªã³ã·ã«åã«ãã€ãŠã¢ãã¹ããªãã¯ãªçµåäœçœ®ã
ä¿è·ãããã®ã§ã¢ãã¹ããªãã¯åã®å¹³è¡¡ç§»åã«å¯
äžããªãããããã€ãŠè¡æ¶²è©Šæäžã®ã°ãªã³ã·ã«å
ãã¢ã°ããã³ããŒã»ã³ããé«ãçšããã¢ã°ããã³
ãšã¢ãã¹ããªãã¯ãªäœçœ®çµåæ§ç©è³ªãšã®åå¿ã«ã
ãã¢ãã¹ããªãã¯åéã®ç§»åã¯å°ãªããåèšçºèŠ
ã¯éã°ãªã³ã·ã«åãã¢ã°ããã³ã«ãããŠèµ·ãæã
ã¢ãã¹ããªãã¯ãªçµåäœçœ®ã®åå¿æ§ããã³ã¢ãã¹
ããªãã¯ãªçµåäœçœ®ç©è³ªãéã°ãªã³ã·ã«åãã¢ã°
ããã³éšåãšåå¿ãããŠåŸãããã°ãªã³ã·ã«åã
ãã³éã°ãªã³ã·ã«åãã¢ã°ããã³ã®ã¢ãã¹ããªã
ã¯åã®å¹³è¡¡ç§»åãå©çšããŠããã éåžžãã¢ã°ããã³ã®ãªã«ã¬ããã¹ããšã€ãçµå
äœçœ®ãšããããæå¹ãªã¢ãã¹ããªãã¯ãªå¥å¹äœäœ
眮çµåæ§ç©è³ªãšããŠçš®ã ã®ååç©ãç¥ãããŠã
ããããã«ã¯ãªã«ã¬ããã¹ããšã€ãé¡ããµã«ããš
ã€ãé¡ãã«ã«ãã³é žé¡ãäŸãã°ã€ãã·ããŒã«ãã¯
ãµãã¹ããšã€ãïŒJ.Biol.Chem.ïŒ246ïŒ7168
ïŒ1971ïŒïŒïŒïŒïŒïŒâãžãã¹ãã°ãªã»ã¬ã€ã
ïŒNatureïŒ234ïŒ174ïŒ1971ïŒïŒïŒã¢ããã·ã³ããªã
ã¹ããšã€ãïŒBiochem.Biophys.Res.Comm.ïŒ
26ïŒ162ïŒ1972ïŒïŒïŒããªãããµã«ãã¹ããšã€ã
ïŒFed.Proc.Fed.Amer.Soc.Expl.Biol.ïŒ28ïŒ604
ïŒ1969ïŒïŒïŒã€ãã·ããŒã«ãã³ã¿ãã¹ããšã€ã
ïŒCan.J.Chem.ïŒ47ïŒ63ïŒ1969ïŒïŒïŒïŒâããããªã
ã·âïŒïŒïŒïŒïŒâãã¬ãããªã¹ã«ããã€ãïŒJ.
Biol.Chem.ïŒ246ïŒ5832ïŒ1971ïŒïŒïŒïŒ¯âã¢ã€ãªã
ãããªãŠã ãã³ãŸãšã€ãïŒThe J.of
Pharmacology and Expel.TherapeuticsïŒ203ïŒ
72ïŒ1977ïŒïŒãããããã¢ã°ããã³æè¡åéã®ç¥è
ããè ã¯åºç¯ãªã¢ãã¹ããªãã¯å¥å¹äœäœçœ®çµåæ§
ç©è³ªãç¥ã€ãŠããã§ããããã€ãã·ããŒã«ãã¯ãµ
ãã¹ããšã€ãã¯å¥œãŸããã¢ãã¹ããªãã¯å¥å¹äœäœ
眮çµåæ§ç©è³ªã§ããã äžè¬ã«ãã¢ã°ããã³ãéé¢ãããã«èµ€è¡çã溶
解ããããšãããèµ€è¡çã溶解ãããã«æ®éã®éœ
ã€ãªã³æ§ïŒäŸãã°ã»ãã«ããªã¡ãã«èåã¢ã³ã¢ã
ãŠã ïŒãé°ã€ãªã³æ§ïŒäŸãã°ããã·ã«ç¡«é žãããª
ãŠã ããã³ããªãã·ã³ãŒã«é žãããªãŠã ïŒããã³
äžæ§ïŒäŸãã°ãµããã³ããã³ãªã¯ãã«ããšãã·ã
ãªãšããªãã·ãšã¿ããŒã«ïŒæž æµå€ãæçšã§ããã
çŽ0.025ä¹è³0.5容éïŒ ã®æ¿åºŠã®äžæ§æž æµå€ã奜ãŸ
ãããæ©æ¢°çé¢æãäŸãã°è¶ é³æ³¢åŠçããã³äœåŒµ
溶解ããŸãèµ€è¡çãããã¢ã°ããã³ãéé¢ããã
æå¹ãªæ¹æ³ã§ããã ãã âçµåæ§é äœåã®ãã éãžã®çµåã¯äžè¬ã«
ã¢ãã¹ããªãã¯ãªãã¢ã°ããã³ç°æ§äœã®å¹³è¡¡ã
åã«ç§»åããããæ ã«è©Šéšè©Šæäžã®ãã¢ã°ããã³
ã®ãã âçµåæ§éšåããã âçµåæ§é äœåãšé äœ
ããå Žåãã¢ã°ããã³ã®ã¢ãã¹ããªãã¯å矀平衡
ã®å€§ããªç§»åãèªããããããã®å¹³è¡¡ç§»åã®æ¡å€§
ã¯ã°ãªã³ã·ã«åãã¢ã°ããã³æž¬å®ç²ŸåºŠãåäžã
ããã¢ãã¹ããªãã¯ç°æ§äœã®å¹³è¡¡ã移åãããã®
ãã âçµåæ§é äœåã®é äœã¯éãFe+2åã¯Fe+3
ïŒã¡ããã¢ã°ããã³ïŒç¶æ ã«ããå Žåå¿çšã§ããã ãã¢ã°ããã³æè¡åéã®ç¥èããè ã¯ãã¢ã°ã
ãã³åã¯ã¡ããã¢ã°ããã³ã®éã«çµåããåºç¯ãª
ãã âçµåæ§é äœåãç¥ã€ãŠããã§ãããã äŸãã°ççŽ ååïŒãïŒããã€ã¢ã«ãã«ã€ãœã·ã¢
ã³åç©é¡åã¯ããšãã«ã€ãœã·ã¢ã³åç©é¡ã®æ§ãªã€
ãœã·ã¢ã³åç©é¡ã¯Fe+2ç¶æ ã«ãããã¢ã°ããã³
ã®ç¹ã«å¥œãŸãããã âçµåæ§é äœåã§ãããä»ã®
é©åœããé äœåã¯O2ããã³NOã§ããã äžè¬ã«éã«çµåããåäžé äœåã¯ã¢ãã¹ããªã
ã¯åã®ç§»åã®ç°¡åãªæž¬å®ãã§ããã®ã§ããããã
ãã€ããšã奜ãŸãããäŸãã°ãªãã·ãã¢ã°ããã³
ïŒã°ãªã³ã·ã«åãããããã³éã°ãªã³ã·ã«åãã
ãïŒã¯ãããªãŠã ãžããªãã€ããšã®åå¿åã¯ä»ã®
æ¢ç¥éå å€ã«ããããªãã·ãã¢ã°ããã³ã«è±é žçŽ
ããããããªãã·ãã¢ã°ããã³ã¯ïœâããã«ã€ãœ
ã·ã¢ã³åç©ã®æ§ãªã¢ã«ãã«ã€ãœã·ã¢ã³åç©ãšåå¿
ãçµæãšããŠã¢ãã¹ããªãã¯å¥å¹äœäœçœ®çµåæ§é
äœåãšã®åå¿ã¯ã¢ãã¹ããªãã¯å平衡ã®æ±ºå®ç移
åããªãã°ãªã³ã·ã«åãã¢ã°ããã³ã®æž¬å®ãå¯èœ
ã«ããã ãã¢ã°ããã³ã¯ããã®åéã§ç¥ãããæ¹æ³ïŒã¢
ã³ãããããã³ãã«ããã®Hemoglobin and
Myoglobin in Their Reaction with LigandsïŒ
1971幎ã¢ã ã¹ãã«ãã ã®ããŒã¹ãã©ã³ããããªã
ã·ã³ã¯ã«ã³ãããŒïŒã«ãã€ãŠã¡ããã¢ã°ããã³ã«
é žåããããæ ã«ããšãªã·ã¢ã³åã«ãªãŠã ãäºç¡
é žãããªãŠã ãã¢ããªã³ããã³ããšãã«ããã©ãž
ã³ã¯ãã¢ã°ããã³ãã¡ããã¢ã°ããã³ã«é žåãã
䟿å©ãªè©Šè¬ã§ãããã¡ãã¬ã³éã®æ§ãªææã®ååš
ã«ãããèªåé žåããŸããã¢ã°ããã³ãã¡ããã¢
ã°ããã³ã«é žåããã éã°ãªã³ã·ã«åãããã¡ããã¢ã°ããã³ã¯éã°
ãªã³ã·ã«åãã¢ã°ããã³ã«ã€ããŠèšèŒããã¢ãã¹
ããªãã¯å¥å¹äœäœçœ®çµåæ§ç©è³ªãšåå¿æ§ã§ããã ãã¢ã°ããã³æè¡åéã®ç¥èããè ã¯ã¡ããã¢
ã°ããã³ãšçµåããåºç¯ãªãã âçµåæ§é äœåã
ç¥ã€ãŠããã§ãããããããã«ã¯ã·ã¢ã³é žå¡©ãã
ãªã·ã¢ã³é žå¡©ãâããããªãã·ã¢ã»ãã¢ããã
ã€ãããŸãŒã«ããã³ãããã®èªå°äœããããïŒã
ã«ããã®BiochemistryïŒ17ïŒ3640â3652
ïŒ1978ïŒïŒã ä»ã®äžè¬é äœåã«ã¯ãµã€åç©ãã¢ãžåç©ãäºç¡
é žå¡©ãã·ã¢ã³åç©ãæ°Žãæ°Žé žåã¢ã³ã¢ãã¢ãé ¢é ž
å¡©ããã³ãé žå¡©ããããçŽ0.1Mã®ã€ãããŸãŒã«
ã¯ã¡ããã¢ã°ããã³ãšäœ¿çšããã«å¥œãŸãããã â
çµåæ§é äœåã§ããã 代衚çã«0.1Mã€ãããŸãŒã«ã0.2mMããšãªã·
ã¢ã³åã«ãªãŠã ãK3FeïŒCNïŒ6ããã³0.05容éïŒ
ããªãã³ïŒžâ100ïŒãªã¯ãã« ããšããªãã·ããªãš
ããªãã·ãšã¿ããŒã«ïŒæž æµå€ãå«ãPH6.8ã®ç·©è¡
液äžã®è©Šè¬ïŒmlãå šè¡10â20ÎŒã«å ãæ··åç©ã
10åéå¹é€ããã ããšãªã·ã¢ã³åã«ãªãŠã ã¯ãã¢ã°ããã³ãã¡ã
ãã¢ã°ããã³ã«é žåãããããªãã³ïŒžâ100ã¯äž
æ§æž æµå€ã§çŽ°èã溶解ããã¢ã°ããã³ãéé¢ã
ããã€ãããŸãŒã«ã¯éãšé äœãã¢ãã¹ããªãã¯ç°
æ§äœã®å¹³è¡¡ãå移åãããã ãã®æ··åç©ã®åžåã¹ãã¯ãã«ã¯560nmãš635nm
ã«æž¬å®ãããã次ãã§0.1Mã€ãã·ããŒã«ãã¯ãµ
ãã¹ããšã€ã溶液2ÎŒïŒPH6.8ïŒãå ããããã®
è©Šè¬ã¯éã°ãªã³ã·ã«åãã¢ã°ããã³ã®ã¢ãã¹ããª
ãã¯ãªçµåäœçœ®ãšåå¿ãã¢ãã¹ããªãã¯ç°æ§äœã®
平衡ãã¿ãŒã²ããåã«ç§»åããããåã³560nm
ãš635nmã®åžåã¹ãã¯ãã«ã枬å®ãããã°ãªã³ã·
ã«åããããã¢ã°ããã³æ¿åºŠã¯560nmåžåã®æžå°
ãš635nmåžåã®å¢å ã«ãã€ãŠãããã è©Šè¬ïŒ¡ïŒæ°Žäž0.1Mã€ãããŸãŒã«ïŒ0.2mMK3Fe
ïŒCNïŒ6ïŒ0.05VïŒïŒ¶ïŒ ããªãã³ïŒžâ100ïŒãªã¯ã
ã«ããšããªãã·ããªãšããªãã·ãšã¿ããŒã«ïŒïŒ
PH6.8ã è©Šè¬ïŒ¢ïŒæ°Žäž0.1Mã€ãã·ããŒã«ãã¯ãµãã¹ããš
ã€ãïŒIHPïŒïŒPH6.8ã 25âã§è©Šè¬A1.0mlã«å šè¡10ã20ÎŒãå ã10å
éå¹é€ããŠçŽ°èã溶解ãããã¢ã°ããã³ãã¡ãã
ã¢ã°ããã³ã«é žåãããç¹ã«5560nmãš635nmã®
åžå 床ãç£èŠããªãã450nmãã700nmã®å¯èŠã¹
ãã¯ãã«ãèšé²ããã次ãã§è©Šè¬B2ÎŒãåå¿æ··
åç©ã«å ãåã³åã®ãšããã¹ãã¯ãã«ãèšé²ã
ãã æ¬çºæã®æ¹æ³ã«ãã€ãŠè£œé ããæšæºæ¶²ãååšã
ãã°ãªã³ã·ã«åãã¢ã°ããã³ã®æž¬å®ã«äœ¿çšããã
ãã¢ã°ããã³æž¬å®çšæšæºæ¶²ã«é¢ããã æ¬çºæã¯è¡æ¶²äžã®ã°ãªã³ã·ã«åãã¢ã°ããã³æž¬
å®ã«äŸ¿å©ãªæšæºè©Šè¬ã«é¢ããããã¢ã°ããã³åã¯
ã¡ããã¢ã°ããã³ãšïŒïŒïŒâãžãããèªå°äœãã
ã¢ã°ããã³ã®ã¢ãã¹ããªãã¯ïŒallostericïŒãªçµ
åäœçœ®ããããã¯ããæ§ãªãã¢ã°ããã³åã¯ã¡ã
ãã¢ã°ããã³ã®ïŒïŒïŒâãžãããããšãã«èªå°äœ
ïŒä¹è³25ïŒ ãšã®æ··åç©ã¯é©åœãªæšæºæ¶²ã§ãããæ
ã«æ¬çºæã®æšæºæ¶²ã¯ãã¢ã°ããã³ã®ïŒ²ããã³ïŒŽå€
æ ã«äŒŽãªãã¹ãã¯ãã«ç¹æ§ã«é¢ããŠã°ãªã³ã·ã«å
ããã³éã°ãªã³ã·ã«åãã¢ã°ããã³ã®æ¬æ··åç©ã
å³ã¡åæã°ãªã³ã·ã«åãã¢ã°ããã³æšæºæ¶²ã§ã
ãããã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³ã®ã®ã¢ã
ã¹ããªãã¯ãªçµåäœçœ®ãïŒïŒïŒâãžãããããšã
ã«èªå°äœã«ãã€ãŠä¿è·ãããŠãããã¢ã°ããã³å
ã¯ã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžãããããšãã«
èªå°äœãïŒïŒ ã11ïŒ ããã³20ïŒ å«ãã§ãã代衚ç
æšæºæ¶²ã¯è©Šéšçšå ·ç®±ã«å ããããã ãã¢ã°ããã³ã¯ïŒã¢ãã¹ããªãã¯ãªåœ¢ã
ïŒtaughtïŒåãšïŒ²ïŒrelaxedïŒåã§ååšããããã
ãã®åã¯ç°ãªãç©ççååŠçæ§è³ªããã¡ïŒ²ãšïŒŽã
ã¢ã°ããã³ã®çžå¯Ÿéã¯çŽ«å€ç·ãèµ€å€ç·ãå¯èŠç·ã
æ žç£æ°å ±é³Žããã³é»ååè»¢å ±é³Žåå åŠã®æ§ãªãã®
åéã§èªããããæ¹æ³ã«ãã€ãŠæž¬å®ã§ãããäŸã
ã°ãã«ããã®Biochemistry17ïŒNo.17ïŒ3641
ïŒ1978ïŒã¯ãã¢ã°ããã³èªå°äœã®åžåã¹ãã¯ãã«ã
å³ã¡ïŒ²â転äœãé äœåãšã€ãã·ããŒã«ãã¯ãµã
ã¹ããšã€ãçµåã®åœæ°ãšããŠèšè¿°ããŠããããã¢
ã°ããã³ã®ïŒ²ãšïŒŽç¶æ ããèå¥ããä»ã®æ¹æ³ã«ã¯
埪ç°ïŒè²æ§ããã³ååŠåå¿æ§ãããããšïŒŽç¶æ
ã®çžå¯Ÿéã¯çµç¹æ³ããã³éåæ³ã®äž¡æ³ã«ãã€ãŠæž¬
å®ã§ããã é«æ¿åºŠã®ã°ãªã³ã·ã«åãã¢ã°ããã³ã¯ç³å°¿ç ã
䌎ãªããšç¥ãããŠãããã°ãªã³ã·ã«åãã¢ã°ãã
ã³ã¯éç³å°¿ç æ£è ã§ã¯å šãã¢ã°ããã³çŽïŒïŒ ã®æ¿
床ã§ããããç³å°¿ç æ£è ã¯ãã®ïŒâïŒåããã€ã
ïŒScienceïŒ200ïŒ1978幎ïŒæïŒæ¥ïŒãã°ãªã³ã·ã«å
ãã¢ã°ããã³æ¿åºŠã¯é·æéã«ãããæ£è ã®å¹³åè¡
ç³æ¿åºŠã®ææ°ãšãªãããã®ææ°ã¯è¡ç³ã®çæå€å
ïŒæéçïŒã«åœ±é¿ãããããããã€ãŠç³å°¿ç æ£è
ã®è¡ç³ç¶æ 調æŽã®æ¯èŒç粟å¯ãªåæ ãšãªãã ã°ãªã³ã·ã«åããããã¢ã°ããã³ã¯éåžžHbA
ãšãããåã¯ãããã¯ãããã°ã©ã管äžè¿ éã«ç§»
åããã®ã§è¿ éãã¢ã°ããã³ãšãããäžè¬ã«ã¯ã
ããã°ã©ãæ³åã¯é»æ°æ³³åæ³ã«ãã€ãŠæž¬å®ãã
ãã æè¿ïŒæ¬åºé¡è ãšå ±éã§ããç±³åœç¹èš±éãçªå·
973368ïŒéã°ãªã³ã·ã«åãã¢ã°ããã³ãã¢ãã¹ã
ãªãã¯ãªäœçœ®çµåæ§ç©è³ªãšåå¿ãããå Žåã®ãã¢
ã°ããã³ã®ïŒ²ãšïŒŽã¢ãã¹ããªãã¯å矀ã®å¹³è¡¡ç§»å
ãç£èŠããããšã«ãã€ãŠè¡æ¶²äžã®ã°ãªã³ã·ã«åã
ã¢ã°ããã³éã枬å®ã§ããããšãçºèŠãããã®ã§
ããããã®åå¿ã¯ãã¢ã°ããã³ã®éã°ãªã³ã·ã«å
éšåã®ïŒ²ããã¢ãã¹ããªãã¯åãžã®ç§»åãèµ·
ããè¡æ¶²è©Šæäžã®ã°ãªã³ã·ã«åãã¢ã°ããã³ã¯ã°
ãªã³ã·ã«åã«ãã€ãŠã¢ãã¹ããªãã¯ãªçµåäœçœ®ã
ä¿è·ãããã®ã§ã¢ãã¹ããªãã¯åã®å¹³è¡¡ç§»åã«å¯
äžããªãããããã€ãŠè¡æ¶²è©Šæäžã®ã°ãªã³ã·ã«å
ãã¢ã°ããã³ããŒã»ã³ããé«ãçšããã¢ã°ããã³
ãšã¢ãã¹ããªãã¯ãªäœçœ®çµåæ§ç©è³ªãšã®åå¿ã«ã
ãã¢ãã¹ããªãã¯åéã®ç§»åã¯å°ãªããåèšçºèŠ
ã¯éã°ãªã³ã·ã«åãã¢ã°ããã³ã«ãããŠèµ·ãæã
ã¢ãã¹ããªãã¯ãªçµåäœçœ®ã®åå¿æ§ããã³ã¢ãã¹
ããªãã¯ãªçµåäœçœ®ç©è³ªãéã°ãªã³ã·ã«åãã¢ã°
ããã³éšåãšåå¿ãããŠåŸãããã°ãªã³ã·ã«åã
ãã³éã°ãªã³ã·ã«åãã¢ã°ããã³ã®ã¢ãã¹ããªã
ã¯åã®å¹³è¡¡ç§»åãå©çšããŠããã éåžžãã¢ã°ããã³ã®ãªã«ã¬ããã¹ããšã€ãçµå
äœçœ®ãšããããæå¹ãªã¢ãã¹ããªãã¯ãªå¥å¹äœäœ
眮çµåæ§ç©è³ªãšããŠçš®ã ã®ååç©ãç¥ãããŠã
ããããã«ã¯ãªã«ã¬ããã¹ããšã€ãé¡ããµã«ããš
ã€ãé¡ãã«ã«ãã³é žé¡ãäŸãã°ã€ãã·ããŒã«ãã¯
ãµãã¹ããšã€ãïŒJ.Biol.Chem.ïŒ246ïŒ7168
ïŒ1971ïŒïŒïŒïŒïŒïŒâãžãã¹ãã°ãªã»ã¬ã€ã
ïŒNatureïŒ234ïŒ174ïŒ1971ïŒïŒïŒã¢ããã·ã³ããªã
ã¹ããšã€ãïŒBiochem.Biophys.Res.Comm.ïŒ
26ïŒ162ïŒ1972ïŒïŒïŒããªãããµã«ãã¹ããšã€ã
ïŒFed.Proc.Fed.Amer.Soc.Expl.Biol.ïŒ28ïŒ604
ïŒ1969ïŒïŒïŒã€ãã·ããŒã«ãã³ã¿ãã¹ããšã€ã
ïŒCan.J.Chem.ïŒ47ïŒ63ïŒ1969ïŒïŒïŒïŒâããããªã
ã·âïŒïŒïŒïŒïŒâãã¬ãããªã¹ã«ããã€ãïŒJ.
Biol.Chem.ïŒ246ïŒ5832ïŒ1971ïŒïŒïŒïŒ¯âã¢ã€ãªã
ãããªãŠã ãã³ãŸãšã€ãïŒThe J.of
Pharmacology and Expel.TherapeuticsïŒ203ïŒ
72ïŒ1977ïŒïŒãããããã¢ã°ããã³æè¡åéã®ç¥è
ããè ã¯åºç¯ãªã¢ãã¹ããªãã¯å¥å¹äœäœçœ®çµåæ§
ç©è³ªãç¥ã€ãŠããã§ããããã€ãã·ããŒã«ãã¯ãµ
ãã¹ããšã€ãã¯å¥œãŸããã¢ãã¹ããªãã¯å¥å¹äœäœ
眮çµåæ§ç©è³ªã§ããã äžè¬ã«ãã¢ã°ããã³ãéé¢ãããã«èµ€è¡çã溶
解ããããšãããèµ€è¡çã溶解ãããã«æ®éã®éœ
ã€ãªã³æ§ïŒäŸãã°ã»ãã«ããªã¡ãã«èåã¢ã³ã¢ã
ãŠã ïŒãé°ã€ãªã³æ§ïŒäŸãã°ããã·ã«ç¡«é žãããª
ãŠã ããã³ããªãã·ã³ãŒã«é žãããªãŠã ïŒããã³
äžæ§ïŒäŸãã°ãµããã³ããã³ãªã¯ãã«ããšãã·ã
ãªãšããªãã·ãšã¿ããŒã«ïŒæž æµå€ãæçšã§ããã
çŽ0.025ä¹è³0.5容éïŒ ã®æ¿åºŠã®äžæ§æž æµå€ã奜ãŸ
ãããæ©æ¢°çé¢æãäŸãã°è¶ é³æ³¢åŠçããã³äœåŒµ
溶解ããŸãèµ€è¡çãããã¢ã°ããã³ãéé¢ããã
æå¹ãªæ¹æ³ã§ããã ãã âçµåæ§é äœåã®ãã éãžã®çµåã¯äžè¬ã«
ã¢ãã¹ããªãã¯ãªãã¢ã°ããã³ç°æ§äœã®å¹³è¡¡ã
åã«ç§»åããããæ ã«è©Šéšè©Šæäžã®ãã¢ã°ããã³
ã®ãã âçµåæ§éšåããã âçµåæ§é äœåãšé äœ
ããå Žåãã¢ã°ããã³ã®ã¢ãã¹ããªãã¯å矀平衡
ã®å€§ããªç§»åãèªããããããã®å¹³è¡¡ç§»åã®æ¡å€§
ã¯ã°ãªã³ã·ã«åãã¢ã°ããã³æž¬å®ç²ŸåºŠãåäžã
ããã¢ãã¹ããªãã¯ç°æ§äœã®å¹³è¡¡ã移åãããã®
ãã âçµåæ§é äœåã®é äœã¯éãFe+2åã¯Fe+3
ïŒã¡ããã¢ã°ããã³ïŒç¶æ ã«ããå Žåå¿çšã§ããã ãã¢ã°ããã³æè¡åéã®ç¥èããè ã¯ãã¢ã°ã
ãã³åã¯ã¡ããã¢ã°ããã³ã®éã«çµåããåºç¯ãª
ãã âçµåæ§é äœåãç¥ã€ãŠããã§ãããã äŸãã°ççŽ ååïŒãïŒããã€ã¢ã«ãã«ã€ãœã·ã¢
ã³åç©é¡åã¯ããšãã«ã€ãœã·ã¢ã³åç©é¡ã®æ§ãªã€
ãœã·ã¢ã³åç©é¡ã¯Fe+2ç¶æ ã«ãããã¢ã°ããã³
ã®ç¹ã«å¥œãŸãããã âçµåæ§é äœåã§ãããä»ã®
é©åœããé äœåã¯O2ããã³NOã§ããã äžè¬ã«éã«çµåããåäžé äœåã¯ã¢ãã¹ããªã
ã¯åã®ç§»åã®ç°¡åãªæž¬å®ãã§ããã®ã§ããããã
ãã€ããšã奜ãŸãããäŸãã°ãªãã·ãã¢ã°ããã³
ïŒã°ãªã³ã·ã«åãããããã³éã°ãªã³ã·ã«åãã
ãïŒã¯ãããªãŠã ãžããªãã€ããšã®åå¿åã¯ä»ã®
æ¢ç¥éå å€ã«ããããªãã·ãã¢ã°ããã³ã«è±é žçŽ
ããããããªãã·ãã¢ã°ããã³ã¯ïœâããã«ã€ãœ
ã·ã¢ã³åç©ã®æ§ãªã¢ã«ãã«ã€ãœã·ã¢ã³åç©ãšåå¿
ãçµæãšããŠã¢ãã¹ããªãã¯å¥å¹äœäœçœ®çµåæ§é
äœåãšã®åå¿ã¯ã¢ãã¹ããªãã¯å平衡ã®æ±ºå®ç移
åããªãã°ãªã³ã·ã«åãã¢ã°ããã³ã®æž¬å®ãå¯èœ
ã«ããã ãã¢ã°ããã³ã¯ããã®åéã§ç¥ãããæ¹æ³ïŒã¢
ã³ãããããã³ãã«ããã®Hemoglobin and
Myoglobin in Their Reaction with LigandsïŒ
1971幎ã¢ã ã¹ãã«ãã ã®ããŒã¹ãã©ã³ããããªã
ã·ã³ã¯ã«ã³ãããŒïŒã«ãã€ãŠã¡ããã¢ã°ããã³ã«
é žåããããæ ã«ããšãªã·ã¢ã³åã«ãªãŠã ãäºç¡
é žãããªãŠã ãã¢ããªã³ããã³ããšãã«ããã©ãž
ã³ã¯ãã¢ã°ããã³ãã¡ããã¢ã°ããã³ã«é žåãã
䟿å©ãªè©Šè¬ã§ãããã¡ãã¬ã³éã®æ§ãªææã®ååš
ã«ãããèªåé žåããŸããã¢ã°ããã³ãã¡ããã¢
ã°ããã³ã«é žåããã éã°ãªã³ã·ã«åãããã¡ããã¢ã°ããã³ã¯éã°
ãªã³ã·ã«åãã¢ã°ããã³ã«ã€ããŠèšèŒããã¢ãã¹
ããªãã¯å¥å¹äœäœçœ®çµåæ§ç©è³ªãšåå¿æ§ã§ããã ãã¢ã°ããã³æè¡åéã®ç¥èããè ã¯ã¡ããã¢
ã°ããã³ãšçµåããåºç¯ãªãã âçµåæ§é äœåã
ç¥ã€ãŠããã§ãããããããã«ã¯ã·ã¢ã³é žå¡©ãã
ãªã·ã¢ã³é žå¡©ãâããããªãã·ã¢ã»ãã¢ããã
ã€ãããŸãŒã«ããã³ãããã®èªå°äœããããïŒã
ã«ããã®BiochemistryïŒ17ïŒ3640â3652
ïŒ1978ïŒïŒã ä»ã®äžè¬é äœåã«ã¯ãµã€åç©ãã¢ãžåç©ãäºç¡
é žå¡©ãã·ã¢ã³åç©ãæ°Žãæ°Žé žåã¢ã³ã¢ãã¢ãé ¢é ž
å¡©ããã³ãé žå¡©ããããçŽ0.1Mã®ã€ãããŸãŒã«
ã¯ã¡ããã¢ã°ããã³ãšäœ¿çšããã«å¥œãŸãããã â
çµåæ§é äœåã§ããã 代衚çã«0.1Mã€ãããŸãŒã«ã0.2mMããšãªã·
ã¢ã³åã«ãªãŠã ãK3FeïŒCNïŒ6ããã³0.05容éïŒ
ããªãã³ïŒžâ100ïŒãªã¯ãã« ããšããªãã·ããªãš
ããªãã·ãšã¿ããŒã«ïŒæž æµå€ãå«ãPH6.8ã®ç·©è¡
液äžã®è©Šè¬ïŒmlãå šè¡10â20ÎŒã«å ãæ··åç©ã
10åéå¹é€ããã ããšãªã·ã¢ã³åã«ãªãŠã ã¯ãã¢ã°ããã³ãã¡ã
ãã¢ã°ããã³ã«é žåãããããªãã³ïŒžâ100ã¯äž
æ§æž æµå€ã§çŽ°èã溶解ããã¢ã°ããã³ãéé¢ã
ããã€ãããŸãŒã«ã¯éãšé äœãã¢ãã¹ããªãã¯ç°
æ§äœã®å¹³è¡¡ãå移åãããã ãã®æ··åç©ã®åžåã¹ãã¯ãã«ã¯560nmãš635nm
ã«æž¬å®ãããã次ãã§0.1Mã€ãã·ããŒã«ãã¯ãµ
ãã¹ããšã€ã溶液2ÎŒïŒPH6.8ïŒãå ããããã®
è©Šè¬ã¯éã°ãªã³ã·ã«åãã¢ã°ããã³ã®ã¢ãã¹ããª
ãã¯ãªçµåäœçœ®ãšåå¿ãã¢ãã¹ããªãã¯ç°æ§äœã®
平衡ãã¿ãŒã²ããåã«ç§»åããããåã³560nm
ãš635nmã®åžåã¹ãã¯ãã«ã枬å®ãããã°ãªã³ã·
ã«åããããã¢ã°ããã³æ¿åºŠã¯560nmåžåã®æžå°
ãš635nmåžåã®å¢å ã«ãã€ãŠãããã è©Šè¬ïŒ¡ïŒæ°Žäž0.1Mã€ãããŸãŒã«ïŒ0.2mMK3Fe
ïŒCNïŒ6ïŒ0.05VïŒïŒ¶ïŒ ããªãã³ïŒžâ100ïŒãªã¯ã
ã«ããšããªãã·ããªãšããªãã·ãšã¿ããŒã«ïŒïŒ
PH6.8ã è©Šè¬ïŒ¢ïŒæ°Žäž0.1Mã€ãã·ããŒã«ãã¯ãµãã¹ããš
ã€ãïŒIHPïŒïŒPH6.8ã 25âã§è©Šè¬A1.0mlã«å šè¡10ã20ÎŒãå ã10å
éå¹é€ããŠçŽ°èã溶解ãããã¢ã°ããã³ãã¡ãã
ã¢ã°ããã³ã«é žåãããç¹ã«5560nmãš635nmã®
åžå 床ãç£èŠããªãã450nmãã700nmã®å¯èŠã¹
ãã¯ãã«ãèšé²ããã次ãã§è©Šè¬B2ÎŒãåå¿æ··
åç©ã«å ãåã³åã®ãšããã¹ãã¯ãã«ãèšé²ã
ãã æ¬çºæã®æ¹æ³ã«ãã€ãŠè£œé ããæšæºæ¶²ãååšã
ãã°ãªã³ã·ã«åãã¢ã°ããã³ã®æž¬å®ã«äœ¿çšããã
ãè¡šã
â³â
â³â
ãã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³ã¯ããâ
ïŒïŒïŒâãžããããã³ãŒã³ïŒäœãããã²ã³ã¯ã¯ã
ãããã«ãªããããã¢åã¯ã¢ã€ãªããšããïŒãšå
å¿ããããšãã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³ã®
ïŒïŒïŒâãžãããããšãã«èªå°äœãçæããã ã¯ãã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³ã®èçœ
質ã§ããã 现èäžåã¯æº¶æ¶²äžã®ãã¢ã°ããã³ã¯éå°ã®ãã
âïŒïŒïŒâãžããããã³ãŒã³ã奜ãŸããã¯ãã«ãª
ãâïŒïŒïŒâãžããããã³ãŒã³ãšåå¿ãããèµ€è¡
çã䜿ã€ãŠç¥äœãåããå Žå现èã¯éå°ã®ïŒïŒïŒ
âãžããããã³ãŒã³ãšåå¿ã溶解ããã¢ã°ããã³
ã¯ã¡ããã¢ã°ããã³ã«é žåãããããã®æäœã§å€
æ°ã®ïŒïŒïŒâãžãããããšãã«åºããã¢ã°ããã³
ã«çµåãããå°ãªããïŒåã®ïŒïŒïŒâãžãããã
ãšãã«åºãã¢ãã¹ããªãã¯ãªçµåäœçœ®ãä¿è·ã
ãããã¢ã°ããã³æº¶æ¶²ã䜿ã€ãŠæäœãåããå Žå
ãã¢ã°ããã³æº¶æ¶²ãäŸãã°ãã«ãªãâïŒïŒïŒâãž
ããããã³ãŒã³ã®éå°ãšåŠçãèªå°çæç©ã¯åé¢
ããããåã¯ã¡ããã¢ã°ããã³ã«é žåããããã
ã¥ããã§ãããäžè¬ã«ã¡ããã¢ã°ããã³èªå°äœã¯
å®å®æ§ãããã®ã§ããã䜿çšããããšã奜ãŸã
ããããããã¢ã°ããã³ãïŒïŒïŒâãžãããããš
ãã«åºã䜿ã€ãŠèªå°äœãšãã¢ãã¹ããªãã¯ãªçµå
äœçœ®ãä¿è·ãããŠããèµ€è¡çã¯10ã30ïŒ ã°ãªã»ã
ãŒã«å¡©æº¶æ¶²ã«æžæ¿ãããã®åœ¢ã§æšæºæ¶²ãšããŠäœ¿çš
ã§ããããšãææããå¿ èŠãããã ïŒâãã«ãªãâïŒïŒïŒâãžããããã³ãŒã³ãšäºº
éã®ãã¢ã°ããã³ã®åå¿ããã³ãã³ãã¢ã ã¹ãã«
ãã ãåãªã©ã³ãåºç瀟1971幎ã®E.ã¢ã³ããããš
M.ãã«ããã®Hemoglobin and Myoglobin In
Their Reaction With LigandïŒ295â296ããŒãž
ã«ãã€ãŠç¥ãããŠããããïŒïŒïŒâãžãããããš
ãã«åºãã¡ããã¢ã°ããã³ã®ã¢ãã¹ããªãã¯ãªçµ
åäœçœ®ãä¿è·ããŠããã¡ããã¢ã°ããã³ã®ïŒïŒïŒ
âãžãããããšãã«èªå°äœã¯ç¥ãããŠããªããã
ïŒïŒïŒâãžãããããšãã«åºããã¢ã°ããã³åã¯
ã¡ããã¢ã°ããã³ã®ã¢ãã¹ããªãã¯ãªçµåäœçœ®ã
ä¿è·ããŠãããã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³
ã®ïŒïŒïŒâãžãããããšãã«èªå°äœã®æšæºæ··åç©
åã¯æº¶æ¶²ãç¥ãããŠããªãã ã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžãããããšãã«
èªå°äœã¯ãã®å®å®æ§ã«ãã€ãŠç¹ã«å¥œãŸããèªå°äœ
ã§ãããã¡ããã¢ã°ããã³ããã³ãã®ã¢ãã¹ããª
ãã¯ãªçµåäœçœ®ãïŒïŒïŒâãžãããããšãã«åºã§
ä¿è·ãããŠããã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžã
ããããšãã«èªå°äœïŒä¹è³25ïŒ ã®æ··åç©ã¯ã°ãªã³
ã·ã«åããããã¢ã°ããã³æž¬å®çšã«ç¹ã«äŸ¿å©ãªæš
æºè©Šæ¶²ã§ããã è©Šéšçšå ·ç®±ã«çšãã奜ãŸããå®æœæ æ§ã«ãããŠ
PHïŒãïŒã®ããé žå¡©ç·©è¡æ¶²äžã®ïŒã15ããªã¢ã«è
çœè³ªæº¶æ¶²äžã¡ããã¢ã°ããã³ããã³ãã®ã¢ãã¹ã
ãªãã¯ãªçµåäœçœ®ãïŒïŒïŒâãžãããããšãã«åº
ã§ä¿è·ãããŠããã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãž
ãããããšãã«èªå°äœïŒïŒ ã11ïŒ ããã³20ïŒ ã®å
æ··åç©åã¯æ°Žæº¶æ¶²ã䜿ãããã æ··åç©ã¯ãŸãåçµç空也ç¥æšæºæ··åç©ãšããŠäœ¿
çšã§ããã æ¬çºæã®æšæºè©Šè¬ã¯ãã¢ã°ããã³ãšã°ãªã³ã·ã«
åãã¢ã°ããã³ã®æ··åç©ã®ä»£ãã«äœ¿ããããã°ãª
ã³ã·ã«åãã¢ã°ããã³ã¯è¡æ¶²ããåé¢åã¯ã°ã«ã³
ãŒã¹ãšãã¢ã°ããã³ã®é µçŽ åå¿ã«ãã€ãŠè£œé ããª
ããã°ãªããªããæ¬çºæã®è©Šè¬ããã³æšæºåã¯ã
ã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³ã®åæèªå°äœã§
ãããããã¯äŸ¿å©ã«è£œé ã§ããããŸãã°ãªã³ã·ã«
åãã¢ã°ããã³æž¬å®çšã®å®å®æšæºæ¶²ãšããŠåœ¹ç«
ã€ã äžèšå®æœäŸã¯æ¬çºæãäŸèšŒããããã®ãã®ã§æ¬
çºæã®çæåã¯ç¯å²ãéå®ããã€ããã¯ãªãã å®æœäŸ ïŒ äººéã®å šè¡ïŒã10ã15åæ¹æãïŒè©Šæã«åå²
ãåã ãé å¿åé¢ç®¡ã«å ¥ã26âã§30åé1800Ãïœ
ä¹è³2000Ãïœã§é å¿åé¢ãããäžæŸæ¶²ãåžåŒãå
管ã«é垞塩溶液300mlãå ããã¥ãã«æ¹æããŠçŽ°
èãåã³æžæ¿ããããé å¿åé¢ãåžåŒããã³åæž
æ¿ãïŒåå埩ããã次ãã§çŽ°èãPH7.2ããé žå¡©
ç·©è¡å¡©æº¶æ¶²250mlã«æžæ¿ããããæžæ¿æ¶²ã䜵ãã
ãã«ïŒâãã«ãªãâïŒïŒïŒâãžããããã³ãŒã³15
mlãå ãåå¿æ··åç©ãçŽ25âã§ïŒæéå¹é€ããã
ïŒâãã«ãªãâïŒïŒïŒâãžããããã³ãŒã³ãšåå¿
ããæžæ¿æ¶²ãåã³ïŒéšåã«åå²ã1800ã2000Ãïœ
ã«ãããŠ15åéé å¿åé¢ãããäžæŸæ¶²ãåŸçããŠ
æšãŠçŽ°èã25âã§çŽïŒæéåã¯ïŒâã§äžå€æ°Žã«æº¶
解ãããã管ã15000ã17000Xgã«ãããŠ30åé
é å¿åé¢ãäžæŸæ¶²ãä¿æãïŒä¹è³ïŒâã§è²¯èµã
ããäžæŸæ¶²äžã®ãã¢ã°ããã³èªå°äœã¯ããšãªã·ã¢
ã³åã«ãªãŠã 11.0ïœãå ããŠã¡ããã¢ã°ããã³ã«
é žåããã ã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžãããããšãã«
èªå°äœã¯æ··ååºã€ãªã³äº€ææš¹èäžã§åé¢ãïŒã¢ã«
ããé žã«ãªãŠã ïŒPH6.2ïŒ1/20容éãå ãããã
ã®æ¶²ãã¢ãã³ã³äžç©ºç¹ç¶éæåšïŒæ¿çž®åšè£ 眮äžã§
éææ¿çž®ããã ã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžãããããšãã«
èªå°äœãã¡ããã¢ã°ããã³ãšæ··åããŠã¡ããã¢ã°
ããã³ã®ïŒïŒïŒâãžãããããšãã«èªå°äœãïŒä¹
è³25ïŒ ã®ç¯å²ã®æšæºæ¶²ãã€ãã€ããæšæºæ¶²ã¯ãã
é žå¡©ç·©è¡æ¶²ïŒPH6.8ïŒå ã«ïŒã15ããªã¢ã«ã®èçœ
質ãå«ã¿ããã®ã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžã
ããããšãã«èªå°äœæ¿åºŠã¯ïŒïŒ ã11ïŒ åã¯20ïŒ ã§
ããã å®æœäŸ ïŒ å®æœäŸïŒã®æ¹æ³ã«ãããã¢ã°ããã³ã®ïŒïŒïŒâ
ãžãããããšãã«èªå°äœã補é ãããäœãããšãª
ã·ã¢ã³åã«ãªãŠã ã«ããé žåå·¥çšãçç¥ããã å®æœäŸ ïŒ èµ€è¡çã®ä»£ãã«ãã¢ã°ããã³æº¶æ¶²ã䜿ã€ãŠæäœ
ãåãåã¯èªå°äœãã€ããåã«èµ€è¡çã溶解ããŠ
å®æœäŸïŒãšïŒã«ãããŠçæããèªå°äœãçæã
ãã å®æœäŸ ïŒ å®æœäŸïŒã®æ¹æ³ã«ããèµ€è¡çäžã®ãã¢ã°ããã³
ãïŒâãã«ãªãâïŒïŒïŒâãžããããã³ãŒã³ã䜿
ã€ãŠèªå°äœãšãèµ€è¡çã¯æº¶è§£ããã«æªåå¿èµ€è¡ç
ãšæ··åãæŽæµã10ã30ïŒ ã°ãªã»ããŒã«ïŒå¡©æº¶æ¶²äž
ã«è²¯èµããŠå®å®æšæºæ¶²ãšããããããŠèµ€è¡çæžæ¿
氎液äžã®ïŒä¹è³25ïŒ ã®èµ€è¡çã¯ãã¢ã°ããã³ã®ã¢
ãã¹ããªãã¯ãªçµåäœçœ®ãïŒïŒïŒâãžãããããš
ãã«åºã§ä¿è·ãããŠãïŒïŒïŒâãžãããããšãã«
ãã¢ã°ããã³ãšãªã€ããã¢ã°ããã³ããã€ãŠã
ããäžè¬ã«10ã30ïŒ ã°ãªã»ããŒã«ã®å¡©æº¶æ¶²äžïŒ
ïŒ ã11ïŒ ããã³20ïŒ æžæ¿æ¶²ãè©Šéšçšå ·ç®±ã«å ãã
ããã
â³â
ãã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³ã¯ããâ
ïŒïŒïŒâãžããããã³ãŒã³ïŒäœãããã²ã³ã¯ã¯ã
ãããã«ãªããããã¢åã¯ã¢ã€ãªããšããïŒãšå
å¿ããããšãã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³ã®
ïŒïŒïŒâãžãããããšãã«èªå°äœãçæããã ã¯ãã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³ã®èçœ
質ã§ããã 现èäžåã¯æº¶æ¶²äžã®ãã¢ã°ããã³ã¯éå°ã®ãã
âïŒïŒïŒâãžããããã³ãŒã³ã奜ãŸããã¯ãã«ãª
ãâïŒïŒïŒâãžããããã³ãŒã³ãšåå¿ãããèµ€è¡
çã䜿ã€ãŠç¥äœãåããå Žå现èã¯éå°ã®ïŒïŒïŒ
âãžããããã³ãŒã³ãšåå¿ã溶解ããã¢ã°ããã³
ã¯ã¡ããã¢ã°ããã³ã«é žåãããããã®æäœã§å€
æ°ã®ïŒïŒïŒâãžãããããšãã«åºããã¢ã°ããã³
ã«çµåãããå°ãªããïŒåã®ïŒïŒïŒâãžãããã
ãšãã«åºãã¢ãã¹ããªãã¯ãªçµåäœçœ®ãä¿è·ã
ãããã¢ã°ããã³æº¶æ¶²ã䜿ã€ãŠæäœãåããå Žå
ãã¢ã°ããã³æº¶æ¶²ãäŸãã°ãã«ãªãâïŒïŒïŒâãž
ããããã³ãŒã³ã®éå°ãšåŠçãèªå°çæç©ã¯åé¢
ããããåã¯ã¡ããã¢ã°ããã³ã«é žåããããã
ã¥ããã§ãããäžè¬ã«ã¡ããã¢ã°ããã³èªå°äœã¯
å®å®æ§ãããã®ã§ããã䜿çšããããšã奜ãŸã
ããããããã¢ã°ããã³ãïŒïŒïŒâãžãããããš
ãã«åºã䜿ã€ãŠèªå°äœãšãã¢ãã¹ããªãã¯ãªçµå
äœçœ®ãä¿è·ãããŠããèµ€è¡çã¯10ã30ïŒ ã°ãªã»ã
ãŒã«å¡©æº¶æ¶²ã«æžæ¿ãããã®åœ¢ã§æšæºæ¶²ãšããŠäœ¿çš
ã§ããããšãææããå¿ èŠãããã ïŒâãã«ãªãâïŒïŒïŒâãžããããã³ãŒã³ãšäºº
éã®ãã¢ã°ããã³ã®åå¿ããã³ãã³ãã¢ã ã¹ãã«
ãã ãåãªã©ã³ãåºç瀟1971幎ã®E.ã¢ã³ããããš
M.ãã«ããã®Hemoglobin and Myoglobin In
Their Reaction With LigandïŒ295â296ããŒãž
ã«ãã€ãŠç¥ãããŠããããïŒïŒïŒâãžãããããš
ãã«åºãã¡ããã¢ã°ããã³ã®ã¢ãã¹ããªãã¯ãªçµ
åäœçœ®ãä¿è·ããŠããã¡ããã¢ã°ããã³ã®ïŒïŒïŒ
âãžãããããšãã«èªå°äœã¯ç¥ãããŠããªããã
ïŒïŒïŒâãžãããããšãã«åºããã¢ã°ããã³åã¯
ã¡ããã¢ã°ããã³ã®ã¢ãã¹ããªãã¯ãªçµåäœçœ®ã
ä¿è·ããŠãããã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³
ã®ïŒïŒïŒâãžãããããšãã«èªå°äœã®æšæºæ··åç©
åã¯æº¶æ¶²ãç¥ãããŠããªãã ã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžãããããšãã«
èªå°äœã¯ãã®å®å®æ§ã«ãã€ãŠç¹ã«å¥œãŸããèªå°äœ
ã§ãããã¡ããã¢ã°ããã³ããã³ãã®ã¢ãã¹ããª
ãã¯ãªçµåäœçœ®ãïŒïŒïŒâãžãããããšãã«åºã§
ä¿è·ãããŠããã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžã
ããããšãã«èªå°äœïŒä¹è³25ïŒ ã®æ··åç©ã¯ã°ãªã³
ã·ã«åããããã¢ã°ããã³æž¬å®çšã«ç¹ã«äŸ¿å©ãªæš
æºè©Šæ¶²ã§ããã è©Šéšçšå ·ç®±ã«çšãã奜ãŸããå®æœæ æ§ã«ãããŠ
PHïŒãïŒã®ããé žå¡©ç·©è¡æ¶²äžã®ïŒã15ããªã¢ã«è
çœè³ªæº¶æ¶²äžã¡ããã¢ã°ããã³ããã³ãã®ã¢ãã¹ã
ãªãã¯ãªçµåäœçœ®ãïŒïŒïŒâãžãããããšãã«åº
ã§ä¿è·ãããŠããã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãž
ãããããšãã«èªå°äœïŒïŒ ã11ïŒ ããã³20ïŒ ã®å
æ··åç©åã¯æ°Žæº¶æ¶²ã䜿ãããã æ··åç©ã¯ãŸãåçµç空也ç¥æšæºæ··åç©ãšããŠäœ¿
çšã§ããã æ¬çºæã®æšæºè©Šè¬ã¯ãã¢ã°ããã³ãšã°ãªã³ã·ã«
åãã¢ã°ããã³ã®æ··åç©ã®ä»£ãã«äœ¿ããããã°ãª
ã³ã·ã«åãã¢ã°ããã³ã¯è¡æ¶²ããåé¢åã¯ã°ã«ã³
ãŒã¹ãšãã¢ã°ããã³ã®é µçŽ åå¿ã«ãã€ãŠè£œé ããª
ããã°ãªããªããæ¬çºæã®è©Šè¬ããã³æšæºåã¯ã
ã¢ã°ããã³åã¯ã¡ããã¢ã°ããã³ã®åæèªå°äœã§
ãããããã¯äŸ¿å©ã«è£œé ã§ããããŸãã°ãªã³ã·ã«
åãã¢ã°ããã³æž¬å®çšã®å®å®æšæºæ¶²ãšããŠåœ¹ç«
ã€ã äžèšå®æœäŸã¯æ¬çºæãäŸèšŒããããã®ãã®ã§æ¬
çºæã®çæåã¯ç¯å²ãéå®ããã€ããã¯ãªãã å®æœäŸ ïŒ äººéã®å šè¡ïŒã10ã15åæ¹æãïŒè©Šæã«åå²
ãåã ãé å¿åé¢ç®¡ã«å ¥ã26âã§30åé1800Ãïœ
ä¹è³2000Ãïœã§é å¿åé¢ãããäžæŸæ¶²ãåžåŒãå
管ã«é垞塩溶液300mlãå ããã¥ãã«æ¹æããŠçŽ°
èãåã³æžæ¿ããããé å¿åé¢ãåžåŒããã³åæž
æ¿ãïŒåå埩ããã次ãã§çŽ°èãPH7.2ããé žå¡©
ç·©è¡å¡©æº¶æ¶²250mlã«æžæ¿ããããæžæ¿æ¶²ã䜵ãã
ãã«ïŒâãã«ãªãâïŒïŒïŒâãžããããã³ãŒã³15
mlãå ãåå¿æ··åç©ãçŽ25âã§ïŒæéå¹é€ããã
ïŒâãã«ãªãâïŒïŒïŒâãžããããã³ãŒã³ãšåå¿
ããæžæ¿æ¶²ãåã³ïŒéšåã«åå²ã1800ã2000Ãïœ
ã«ãããŠ15åéé å¿åé¢ãããäžæŸæ¶²ãåŸçããŠ
æšãŠçŽ°èã25âã§çŽïŒæéåã¯ïŒâã§äžå€æ°Žã«æº¶
解ãããã管ã15000ã17000Xgã«ãããŠ30åé
é å¿åé¢ãäžæŸæ¶²ãä¿æãïŒä¹è³ïŒâã§è²¯èµã
ããäžæŸæ¶²äžã®ãã¢ã°ããã³èªå°äœã¯ããšãªã·ã¢
ã³åã«ãªãŠã 11.0ïœãå ããŠã¡ããã¢ã°ããã³ã«
é žåããã ã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžãããããšãã«
èªå°äœã¯æ··ååºã€ãªã³äº€ææš¹èäžã§åé¢ãïŒã¢ã«
ããé žã«ãªãŠã ïŒPH6.2ïŒ1/20容éãå ãããã
ã®æ¶²ãã¢ãã³ã³äžç©ºç¹ç¶éæåšïŒæ¿çž®åšè£ 眮äžã§
éææ¿çž®ããã ã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžãããããšãã«
èªå°äœãã¡ããã¢ã°ããã³ãšæ··åããŠã¡ããã¢ã°
ããã³ã®ïŒïŒïŒâãžãããããšãã«èªå°äœãïŒä¹
è³25ïŒ ã®ç¯å²ã®æšæºæ¶²ãã€ãã€ããæšæºæ¶²ã¯ãã
é žå¡©ç·©è¡æ¶²ïŒPH6.8ïŒå ã«ïŒã15ããªã¢ã«ã®èçœ
質ãå«ã¿ããã®ã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžã
ããããšãã«èªå°äœæ¿åºŠã¯ïŒïŒ ã11ïŒ åã¯20ïŒ ã§
ããã å®æœäŸ ïŒ å®æœäŸïŒã®æ¹æ³ã«ãããã¢ã°ããã³ã®ïŒïŒïŒâ
ãžãããããšãã«èªå°äœã補é ãããäœãããšãª
ã·ã¢ã³åã«ãªãŠã ã«ããé žåå·¥çšãçç¥ããã å®æœäŸ ïŒ èµ€è¡çã®ä»£ãã«ãã¢ã°ããã³æº¶æ¶²ã䜿ã€ãŠæäœ
ãåãåã¯èªå°äœãã€ããåã«èµ€è¡çã溶解ããŠ
å®æœäŸïŒãšïŒã«ãããŠçæããèªå°äœãçæã
ãã å®æœäŸ ïŒ å®æœäŸïŒã®æ¹æ³ã«ããèµ€è¡çäžã®ãã¢ã°ããã³
ãïŒâãã«ãªãâïŒïŒïŒâãžããããã³ãŒã³ã䜿
ã€ãŠèªå°äœãšãèµ€è¡çã¯æº¶è§£ããã«æªåå¿èµ€è¡ç
ãšæ··åãæŽæµã10ã30ïŒ ã°ãªã»ããŒã«ïŒå¡©æº¶æ¶²äž
ã«è²¯èµããŠå®å®æšæºæ¶²ãšããããããŠèµ€è¡çæžæ¿
氎液äžã®ïŒä¹è³25ïŒ ã®èµ€è¡çã¯ãã¢ã°ããã³ã®ã¢
ãã¹ããªãã¯ãªçµåäœçœ®ãïŒïŒïŒâãžãããããš
ãã«åºã§ä¿è·ãããŠãïŒïŒïŒâãžãããããšãã«
ãã¢ã°ããã³ãšãªã€ããã¢ã°ããã³ããã€ãŠã
ããäžè¬ã«10ã30ïŒ ã°ãªã»ããŒã«ã®å¡©æº¶æ¶²äžïŒ
ïŒ ã11ïŒ ããã³20ïŒ æžæ¿æ¶²ãè©Šéšçšå ·ç®±ã«å ãã
ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ãã¢ã°ããã³ããã³ãã®ã¢ãã¹ããªãã¯ãªçµ
åäœçœ®ãïŒïŒïŒâãžãããããšãã«åºã§ä¿è·ãã
ãŠãããã¢ã°ããã³ã®ïŒïŒïŒâãžãããããšãã«
èªå°äœïŒä¹è³25ïŒ ã®æ··åç©ããæãããšãç¹åŸŽãš
ããã°ãªã³ã·ã«åããããã¢ã°ããã³æž¬å®çšæšæº
液ã ïŒ æ°Žæº¶æ¶²äžã®æ··åç©æ¿åºŠãïŒä¹è³15ããªã¢ã«ã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æ¹æ³ã ïŒ ã¡ããã¢ã°ããã³ããã³ãã®ã¢ãã¹ããªãã¯
ãªçµåäœçœ®ãïŒïŒïŒâãžãããããšãã«åºã§ä¿è·
ãããŠããã¡ããã¢ã°ããã³ã®ïŒïŒïŒâãžããã
ããšãã«èªå°äœïŒä¹è³25ïŒ ã®æ··åç©ããæãããš
ãç¹åŸŽãšããã°ãªã³ã·ã«åããããã¢ã°ããã³æž¬
å®çšæšæºæ¶²ã ïŒ æ°Žæº¶æ¶²äžã®æ··åç©æ¿åºŠãïŒä¹è³15ããªã¢ã«ã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æšæºæ¶²ã ïŒ ïŒä¹è³25ïŒ ã®èµ€è¡çããã¢ã°ããã³ã®ã¢ãã¹
ããªãã¯ãªçµåäœçœ®ãïŒïŒïŒâãžãããããšãã«
åºã§ä¿è·ãããŠïŒïŒïŒâãžãããããšãã«ãã¢ã°
ããã³ãšãªã€ãŠãããã¢ã°ããã³ããã€èµ€è¡çã®
æžæ¿æ¶²ããæãããšãç¹åŸŽãšããã°ãªã³ã·ã«åã
ã¢ã°ããã³æž¬å®çšæšæºæ¶²ã ïŒ æžæ¿æ¶²ã10ä¹è³30ïŒ ã°ãªã»ããŒã«ã®å¡©æº¶æ¶²ã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æšæºæ¶²ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/101,341 US4274978A (en) | 1979-12-07 | 1979-12-07 | Standards for determining glycosylated hemoglobin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5692457A JPS5692457A (en) | 1981-07-27 |
| JPS6318706B2 true JPS6318706B2 (ja) | 1988-04-19 |
Family
ID=22284137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16920780A Granted JPS5692457A (en) | 1979-12-07 | 1980-12-02 | Glycosylateddhemoglobin measuring standardd solution |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4274978A (ja) |
| JP (1) | JPS5692457A (ja) |
| BE (1) | BE886527A (ja) |
| CA (1) | CA1129313A (ja) |
| DE (1) | DE3045995C2 (ja) |
| FR (1) | FR2471605B1 (ja) |
| GB (1) | GB2064766B (ja) |
| IT (1) | IT1141119B (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0312498U (ja) * | 1989-06-20 | 1991-02-07 |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4629692A (en) * | 1982-12-06 | 1986-12-16 | Miles Laboratories, Inc. | Immunoassay for nonenzymatically glucosylated proteins and protein fragments an index of glycemia |
| DE3532868A1 (de) * | 1985-09-14 | 1987-03-26 | Boehringer Mannheim Gmbh | Verfahren und reagenz zur bestimmung von glykosiliertem haemoglobin sowie hierzu geeignete verbindungen und verfahren zu deren herstellung |
| DE3822749A1 (de) * | 1988-07-05 | 1990-01-11 | Boehringer Mannheim Gmbh | Fructosamin-calibrator |
| US5132230A (en) * | 1989-03-28 | 1992-07-21 | Isolab, Inc. | Primary standard and method of making secondary standards for calibration of glycated protein assays |
| EP0590047A1 (en) * | 1991-06-19 | 1994-04-06 | Abbott Laboratories | Rapid determination of glycated hemoglobin |
| JP3523878B2 (ja) * | 1994-03-11 | 2004-04-26 | ã¢ãããã»ã©ãã©ããªãŒãº | ãã¢ã°ããã³ã®å®éçšç¡ã·ã¢ã³åç©è©Šè¬åã³æ¹æ³ |
| US7361513B2 (en) * | 2005-04-08 | 2008-04-22 | Streck, Inc. | Cellular controls for glycated hemoglobin Hb A1c |
| US7521244B2 (en) * | 2006-10-26 | 2009-04-21 | Bionostics, Inc. | Standard reference solutions |
| EP4465017B1 (en) | 2014-09-30 | 2026-07-15 | Siemens Healthcare Diagnostics Inc. | System for determining the amount of hemoglobin in a plasma fraction |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3876375A (en) * | 1971-11-22 | 1975-04-08 | Jonas Maurukas | Biological composition for use as a reference control in diagnostic analysis |
| US3977995A (en) * | 1974-10-17 | 1976-08-31 | Baxter Laboratories, Inc. | Calibrating fluid for blood cell counting and hemoglobin determination |
| US3964865A (en) * | 1975-01-30 | 1976-06-22 | Sigma Chemical Company | Lyophilized human hemoglobin standard for colorimetric determination of total hemoglobin |
| US4200435A (en) * | 1978-12-26 | 1980-04-29 | Abbott Laboratories | Determination of glycosylated hemoglobin in blood |
-
1979
- 1979-12-07 US US06/101,341 patent/US4274978A/en not_active Expired - Lifetime
-
1980
- 1980-09-09 CA CA359,914A patent/CA1129313A/en not_active Expired
- 1980-09-11 GB GB8029340A patent/GB2064766B/en not_active Expired
- 1980-12-02 JP JP16920780A patent/JPS5692457A/ja active Granted
- 1980-12-05 IT IT26471/80A patent/IT1141119B/it active
- 1980-12-05 FR FR8025918A patent/FR2471605B1/fr not_active Expired
- 1980-12-05 DE DE3045995A patent/DE3045995C2/de not_active Expired
- 1980-12-05 BE BE0/203069A patent/BE886527A/fr not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0312498U (ja) * | 1989-06-20 | 1991-02-07 |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2064766A (en) | 1981-06-17 |
| IT1141119B (it) | 1986-10-01 |
| DE3045995A1 (de) | 1981-09-03 |
| DE3045995C2 (de) | 1983-01-27 |
| FR2471605A1 (fr) | 1981-06-19 |
| FR2471605B1 (fr) | 1985-06-21 |
| GB2064766B (en) | 1983-11-30 |
| US4274978A (en) | 1981-06-23 |
| IT8026471A0 (it) | 1980-12-05 |
| JPS5692457A (en) | 1981-07-27 |
| CA1129313A (en) | 1982-08-10 |
| BE886527A (fr) | 1981-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4200435A (en) | Determination of glycosylated hemoglobin in blood | |
| Klenk et al. | Determination of glycosylated hemoglobin by affinity chromatography: comparison with colorimetric and ion-exchange methods, and effects of common interferences. | |
| US4255385A (en) | Reagent and test kit for determining glycosylated hemoglobin | |
| Lamola et al. | Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. II. Different binding of erythrocyte protoporphyrin to hemoglobin. | |
| Riggs | The metamorphosis of hemoglobin in the bullfrog | |
| Passon et al. | Soluble cytochrome b5 from human erythrocytes | |
| Jensen et al. | Hemoglobin Syracuse (alpha2beta2-143 (H21) His leads to Pro), a new high-affinity variant detected by special electrophoretic methods. Observations on the auto-oxidation of normal and variant hemoglobins. | |
| EP0030378B1 (en) | Glycosylated hemoglobin standards | |
| US4274978A (en) | Standards for determining glycosylated hemoglobin | |
| CA1199257A (en) | Determination of glycosilated haemoglobin | |
| Moss et al. | Magnetic susceptibility evidence for a binuclear iron complex in hemerythrin | |
| Costa et al. | Involvement of a labile axial histidine in coupling electron and proton transfer in Methylophilus methylotrophus cytochrome c â³ | |
| Ueno et al. | Activation mechanism of prostaglandin endoperoxide synthetase by hemoproteins. | |
| Waks et al. | Structural studies of haptoglobins: III. Interactions with hemoglobin | |
| Van Assendelft et al. | The formation of haemiglobin using nitrites | |
| US4590164A (en) | Process for the preparation of a glucose-free hemoglobin standard | |
| Hamada et al. | Hemoglobins from Ascaris lumbricoides I. Purification of hemoglobin from body-wall tissue and its spectral properties | |
| Fukai et al. | A novel role of fatty acid-binding protein as a vehicle of retinoids | |
| HAMADA et al. | Hemoglobins from erythrocytes of eel, Anguilla japonica | |
| HÀnisch et al. | Ligand induced conformational changes in various normal and modified hemoglobins as indicated by changes in optical rotatory dispersion | |
| Malencik et al. | Fluorescence polarization studies of the self-association of beef liver glutamate dehydrogenase | |
| Matsuoka et al. | The dimer-monomer conversion of Cerithidea myoglobin coupled with the heme iron oxidation | |
| Soni et al. | The pH-dependent Soret difference spectra of the deoxy and carbonmonoxy forms of human hemoglobin and its derivatives | |
| JPS59143957A (ja) | ãããã¢ã°ããã³ã®åææ¹æ³ | |
| Arai et al. | Properties and radioimmunoassay of canine Factor X |